Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1

Taken together, interference with CHD1L inhibited the malignant progression and enhanced cisplatin sensitivity of OC cells by binding PLK1.

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2025-02-24
DOI
https://doi.org/10.1186/s13048-024-01582-2
Citations
2
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1

Wenjing Xing, Yuanxiazi Guan, Kun Qiao
2 citations
Journal of Ovarian Research
Ferroptosis and cancer prognosis
3.04
article

Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1

Wenjing Xing, Yuanxiazi Guan, Kun Qiao
article en
2 citations

Abstract

Taken together, interference with CHD1L inhibited the malignant progression and enhanced cisplatin sensitivity of OC cells by binding PLK1.

Journal of Ovarian ResearchVol. 18(1)
Qingdao University (CN), Harbin Medical University (CN), Shandong Tumor Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 11%
Ferroptosis and cancer prognosis
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.